Showing results (1571-1580 of 1,857) with videos related to

Sort By:
Pageof 186
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant gliomaChristine K Cheng, W Clay Gustafson, Elizabeth Charron, et al.
Cell|May 2, 2006
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signalingZachary A Knight, Beatriz Gonzalez, Morri E Feldman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 30, 2013
Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKDMatthew J Damasiewicz, Dianna J Magliano, Robin M Daly, et al.
BMC Nephrology|June 28, 2015
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modificationsAndrea K Viecelli, Elaine Pascoe, Kevan R Polkinghorne, et al.
Diabetes Care|August 23, 2022
The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to RiskHeba M Ismail, David Cuthbertson, Stephen E Gitelman, et al.
Plos One|July 16, 2019
The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative studyEdward Zimbudzi, Clement Lo, Tracy Robinson, et al.
Kidney International|May 12, 2016
Long-term outcomes of end-stage kidney disease for patients with lupus nephritisLei Zhang, Gavin Lee, Xusheng Liu, et al.
Diabetes|July 10, 2013
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of respondersKevan C Herold, Stephen E Gitelman, Mario R Ehlers, et al.
Diabetologia|December 21, 2018
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosisAna Luisa Perdigoto, Paula Preston-Hurlburt, Pamela Clark, et al.
European Heart Journal|February 2, 2008
Innovations in imaging for chronic total occlusions: a glimpse into the future of angiography's blind-spotBrian K Courtney, Nigel R Munce, Kevan J Anderson, et al.
Pageof 186